Skip to main content

Biopharma Startups

Updated August 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 885 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
885
Total Funding
$1.0B
Avg Funding
$40.5M
Global Reach
8
countries

Top Cities for Biopharma

Henderson
Berkeley
Exton
Cambridge
Budapest
Madison

Recently Funded Companies

Export
Henderson, United States

Zura Bio is a clinical-stage, multi-asset biotechnology company.

$144.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Berkeley, United States

Onyx Bio is a biotech company that offers a virtual immune system for faster and safer development of precision medicines

$8.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Exton, United States

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

$75.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

$150.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Budapest, Hungary

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

$25.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Madison, United States

Stem Pharm's synthetic biomaterials support the optimization of cell expansion.

$75K raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

$3.7M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Saintes, Belgium

BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.

$540K raised
Feb 2024

Founder Contacts

41,000+ verified contacts

New York, United States

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

$230.0M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Glasgow, United Kingdom

Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health.

$10.5M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Abingdon, United Kingdom

Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.

$667K raised
Feb 2022

Founder Contacts

41,000+ verified contacts

Dublin, Ireland

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

$125.0M raised
Feb 2022

Founder Contacts

41,000+ verified contacts

New York, United States

Ambient Multimodal AI for Mental Health

Feb 2025

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom

Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.

$2.4M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden

Technologies for the next generation of antibody therapies.

Feb 2026

Founder Contacts

41,000+ verified contacts

Albuquerque, United States

YEEO Eco-Safe develops insect control products using plant-derived essential oils combined with yeast encapsulation technology.

$1.1M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Madrid, Spain

AptaTargets is a biopharmaceutical company focused in developing therapeutic

Feb 2024

Founder Contacts

41,000+ verified contacts

Dundee, United Kingdom

PhaSER Biomedical discovery and develops human like predictions of drug efficacy.

$2.3M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Schlieren, Switzerland

LimmaTech Biologics is a biotech company that develops vaccines to prevent microbial infections and address antimicrobial resistance.

$6.5M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Lidingö, Sweden

This company is a Swedish medical technology company focused on improving the diagnosis and treatment of breast cancer.

$1.3M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Boston, United States

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

$193.0M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Syracuse, United States

BioNeex is a biopharma R&D open exchange platform and two-sided marketplace that directly connects biotech and biopharmaceutical.

$500K raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Ithaca, United States

Protogenix is developing a novel platform for protein production to replace the mammalian system.

$250K raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Tarpon Springs, United States

A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.

$3.3M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Carmel, United States

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

$30.0M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Showing 426 to 450 of 885 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 885 biopharma companies tracked in the VCBacked database.

Average Funding
$40.5M
Total Funding Tracked
$1.0B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.New York
2 companies$230.0M
2.Henderson
1 companies$144.0M
3.Berkeley
1 companies$8.0M
4.Exton
1 companies$75.0M
5.Cambridge
1 companies$150.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

885 Biopharma Startups (2026) — Recently Funded — Page 18 | VCBacked